Feb. 10, 2021

ABOUT THIS EPISODE

Morgans Senior Analysis, Dr. Derek Jellinek, provides an update on the healthcare universe, including key upcoming catalysts.

Check out more from Morgans:

Visit the Morgans website: www.morgans.com.au
Check out our blog: www.morgans.com.au/Blog

On Facebook: www.facebook.com/MorgansAU
On Instagram: www.instagram.com/Morgans.Australia
On Twitter: twitter.com/MorgansAU

#Healthcare #Stocks #ReportingSeason

Business

Investing

English

Australia

Use API to fetch this episode in JSON

IN THIS EPISODE

# derek jellinek

Edit these tags

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript

Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Morgans Under the Microscope.

Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Under the microscope: Micro X - Peter Rowland, CEO

Jan. 19, 2021

Scott Power from the Morgans Healthcare team speaks with Peter Rowland, CEO from Micro-X (ASX: MX1) where he explains the technology, its application, and upcoming catalysts for 2021.

00:15:53

SAVE

CLIP

Under the microscope: Swift Media (ASX:SW1) - Pippa Leary, Chief Executive Officer

Feb. 4, 2021

Morgans Healthcare Analyst Iain Wilkie talks to Pippa Leary, Chief Executive Officer of Swift Media (ASX:SW1) for a high-level overview of the business, catalysts, and its shift into the large aged care sector.

00:07:27

SAVE

CLIP

Under the microscope: ResApp (ASX:RAP) – Tony Keating, CEO and MD

March 25, 2021

Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events.Check out more from Morgans:Visit the Morgans website: www.morgans.com.auCheck out our blog: www.morgans.com.au/BlogOn F…

00:04:51

SAVE

CLIP

Under the microscope: Weekly Wrap Week Ending 15 January 2021

Jan. 15, 2021

Healthcare analysts Iain Wilkie and Scott Power wrap up the week with a review and call out on stocks in the IVF sector such as: Virtus Health (VRT) and Monash IVF Group (MVF). Some other stocks mentioned are ImexHS (IME), Swift Media (SW1), and Impedimed (IPD).

00:06:04

SAVE

CLIP

Disclaimer: The podcast and artwork embedded on this page are from Morgans Financial Limited, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.